HomeCompareVSEQX vs JNJ

VSEQX vs JNJ: Dividend Comparison 2026

VSEQX yields 11.28% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VSEQX wins by $22.1K in total portfolio value
10 years
VSEQX
VSEQX
● Live price
11.28%
Share price
$37.10
Annual div
$4.18
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.1K
Annual income
$2,284.52
Full VSEQX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — VSEQX vs JNJ

📍 VSEQX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVSEQXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VSEQX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VSEQX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VSEQX
Annual income on $10K today (after 15% tax)
$958.82/yr
After 10yr DRIP, annual income (after tax)
$1,941.84/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, VSEQX beats the other by $1,238.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VSEQX + JNJ for your $10,000?

VSEQX: 50%JNJ: 50%
100% JNJ50/50100% VSEQX
Portfolio after 10yr
$31.1K
Annual income
$1,556.15/yr
Blended yield
5.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VSEQX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VSEQX buys
0
JNJ buys
0
No recent congressional trades found for VSEQX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVSEQXJNJ
Forward yield11.28%3.36%
Annual dividend / share$4.18$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$42.1K$20.0K
Annual income after 10y$2,284.52$827.78
Total dividends collected$17.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VSEQX vs JNJ ($10,000, DRIP)

YearVSEQX PortfolioVSEQX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,828$1,128.02$10,676$355.77+$1.2KVSEQX
2$13,903$1,246.94$11,407$389.39+$2.5KVSEQX
3$16,246$1,369.80$12,198$426.53+$4.0KVSEQX
4$18,879$1,495.93$13,056$467.62+$5.8KVSEQX
5$21,825$1,624.66$13,987$513.12+$7.8KVSEQX
6$25,108$1,755.33$14,998$563.56+$10.1KVSEQX
7$28,753$1,887.27$16,098$619.52+$12.7KVSEQX
8$32,786$2,019.84$17,295$681.69+$15.5KVSEQX
9$37,233$2,152.45$18,599$750.82+$18.6KVSEQX
10$42,124$2,284.52$20,022$827.78+$22.1KVSEQX

VSEQX vs JNJ: Complete Analysis 2026

VSEQXStock

This actively managed fund purchases mid- and small-capitalization stocks that the advisor believes have above-average growth potential. The advisor relies on a computer-driven stock selection process in an attempt to build a portfolio with risk characteristics similar to those of the fund’s comparative index, while seeking to provide better returns. Because it focuses on medium-sized and smaller companies, the fund’s performance may be more volatile than that of the broad U.S. stock market. This fund may be considered complementary to a long-term portfolio with large-cap exposure.

Full VSEQX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this VSEQX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VSEQX vs SCHDVSEQX vs JEPIVSEQX vs OVSEQX vs KOVSEQX vs MAINVSEQX vs ABBVVSEQX vs MRKVSEQX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.